Menu

About Us
GeM Registration
Company Insights

Department of Military Affairs Tender by Indian Army (GEM/2025/B/6155775)

D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Di

Darjeeling, West bengal
Goods
Qty:11.6K
EMD: ₹158
EST Bid: ₹10.3 Lakh
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6155775)

Tender Timeline

Tender Issue
April 30, 2025 at 9:12 PM

Tender Title: DRUGS AND PHARMACEUTICALS

Reference Number: GEM/2025/B/6155775

Issuing Authority:

The tender is issued by the Department of Military Affairs, under the Ministry of Defence. This department is responsible for procurement related to pharmaceuticals and medical supplies for military personnel, ensuring that health standards and requirements are met.

Scope of Work and Objectives:

The objective of this tender is to procure D IFA RE 21 Human Insulin Analogue Long Acting Basal Injection (100 IU/ml), which is categorized as a recombinant DNA-origin product. The buyer seeks to acquire a total quantity of 11,602 units, all supplied in disposable pens with 5 needles per pen. This procurement aims to enhance the healthcare capabilities of the military workforce by providing necessary and effective medical supplies.

Eligibility Criteria:

Eligible bidders should be registered entities with relevant qualifications and certifications in the field of pharmaceuticals. Bidders must demonstrate compliance with applicable regulatory standards and demonstrate experience in supplying similar pharmaceutical products to governmental agencies or large institutions.

Technical Requirements:

Bidders must offer products that meet the following specifications:

  • Type: Long-acting insulin analogue.
  • Concentration: 100 IU/ml.
  • Production Origin: Recombinant DNA technology.
  • Packaging: Each pen should be equipped with 5 needles.

Documentation proving regulatory compliance and quality assurance must be submitted. Compliance with Good Manufacturing Practices (GMP) and relevant certifications from health authorities is mandatory.

Financial Requirements:

Bidders are required to submit their financial proposals along with all necessary supporting documents, including pricing information, payment terms, and any contingent liabilities. Independent verification of financial claims may be necessary during the evaluation process.

Document Submission Details:

All tenders must be submitted through the designated online procurement portal. Bidders must ensure that all required documentation is completed accurately and comprehensively, following the established guidelines outlined in the tender document.

Special Provisions:

This tender includes benefits for Micro, Small, and Medium Enterprises (MSEs) and provides provisions to promote startups. Bidders claiming these benefits should include relevant certification indicating their MSE or startup status.

Evaluation Process:

The evaluation of tender submissions will be based on a comprehensive assessment of the technical specifications, financial proposals, and the bidders' overall capability to deliver the required products. The evaluation team will prioritize compliance with defined quality standards and previous performance records.

Delivery Locations:

Deliveries are to be made to specified military facilities as outlined in the resulting contract. Bidders must ensure they can meet delivery timelines and logistical requirements that adhere to government procurement protocols.

Contact Information:

For any queries regarding this tender, interested parties should refer to the official website of the Department of Military Affairs or the Ministry of Defence for further guidance, ensuring communication aligns with procurement protocol.

This tender provides an opportunity for qualified suppliers to engage in crucial healthcare support for military personnel, facilitating the ongoing commitment of the Ministry of Defence to uphold high standards of medical care.

Tender BOQ Items

50 Items
1.

D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Disposable Pen with 5 needles per pen

Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Disposable Pen with 5 needles per pen

Qty:150
Unit:pen
30
2.

D IFA RE 21 Gliclazide MR 30 mg Tab

Gliclazide MR 30 mg Tab

Qty:100
Unit:no
30
3.

D IFA RE 21 Glipizide 5mg Tab

Glipizide 5mg Tab

Qty:100
Unit:no
30
4.

D IFA RE 21 Sitagliptin 50 mg Metformin 1000 mg Tab

Sitagliptin 50 mg Metformin 1000 mg Tab

Qty:1300
Unit:no
30
5.

D IFA RE 21 Insulin Lispro Biphasic injection I DOT P 25 Insulin Lispro and 75 Insulin Lispro protamine suspension

Insulin Lispro Biphasic injection I DOT P 25 Insulin Lispro and 75 Insulin Lispro protamine suspension

Qty:10
Unit:pfp pfs
30
6.

D IFA RE 21 Sirolimus 1mg Tab

Sirolimus 1mg Tab

Qty:1500
Unit:no
30
7.

D IFA RE 21 Pioglitazone Hydrochloride 15mg Tab

Pioglitazone Hydrochloride 15mg Tab

Qty:1200
Unit:no
30
8.

D IFA RE 21 Alendronate Sodium 70mg Tab

Alendronate Sodium 70mg Tab

Qty:300
Unit:no
30
9.

D IFA RE 21 Neostigmine 0 DOT 5mg 1ml Inj

Neostigmine 0 DOT 5mg 1ml Inj

Qty:750
Unit:amp vial
30
10.

D IFA RE 21 Cisatracurium 2 mg ml Inj 10ml vial

Cisatracurium 2 mg ml Inj 10ml vial

Qty:20
Unit:vial
30
11.

D IFA RE 21 Tacrolimus 1mg Prolonged Release Cap

Tacrolimus 1mg Prolonged Release Cap

Qty:1300
Unit:no
30
12.

D IFA RE 21 Mycophenolate Mofetil 750mg Tab

Mycophenolate Mofetil 750mg Tab

Qty:400
Unit:no
30
13.

D IFA RE 21 Intravenous Immunoglobulin IvIg 10gm Bott of 50ml

Intravenous Immunoglobulin IvIg 10gm Bott of 50ml

Qty:35
Unit:bott
30
14.

D IFA RE 21 Calcium Phosphate 0 DOT 24 mg 5 ml Syp

Calcium Phosphate 0 DOT 24 mg 5 ml Syp

Qty:40
Unit:bott
30
15.

D IFA RE 21 Calcium Acetate 500 mg Tab

Calcium Acetate 500 mg Tab

Qty:100
Unit:no
30
16.

D IFA RE 21 Carnitine 200 mg Tab

Carnitine 200 mg Tab

Qty:100
Unit:no
30
17.

D IFA RE 21 Acyclovir Ophth Ointment 3 w w in 5 gm tube

Acyclovir Ophth Ointment 3 w w in 5 gm tube

Qty:15
Unit:tube
30
18.

D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Tube of 5 gm

Ciprofloxacin HCl 0 DOT 3 Tube of 5 gm

Qty:17
Unit:tube
30
19.

D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Dexamethasone DOT 1 bott of 5ml

Ciprofloxacin HCl 0 DOT 3 Dexamethasone 0 DOT 1 bott of 5ml

Qty:25
Unit:bott
30
20.

D IFA RE 21 Cyclosporine eye drop 0 DOT 05 bott of 3 ml

Cyclosporine eye drop 0 DOT 05 bott of 3 ml

Qty:235
Unit:bott
30
21.

D IFA RE 21 Fluorescein Sodium 20 3 ml Inj

Fluorescein Sodium 20 3 ml Inj

Qty:15
Unit:amp vial
30
22.

D IFA RE 21 Flurbiprofen Sodium ophthalmic soln 0 DOT 03 vial of 5 ml

Flurbiprofen Sodium ophthalmic soln 0 DOT 03 vial of 5 ml

Qty:15
Unit:amp vial
30
23.

D IFA RE 21 Homatropine Hydrochloride Soln 2

Homatropine Hydrochloride Soln 2

Qty:4
Unit:bott
30
24.

D IFA RE 21 Ketorolac Tromethamine 0 DOT 4 Eye drops

Ketorolac Tromethamine 0 DOT 4 Eye drops

Qty:50
Unit:bott
30
25.

D IFA RE 21 Natamycin 3 eye drops in 3 ml bott

Natamycin 3 eye drops in 3 ml bott

Qty:30
Unit:bott
30
26.

D IFA RE 21 Carboxy Methyl Cellulose CMC 1 Gel

Carboxy Methyl Cellulose CMC 1 Gel

Qty:63
Unit:bott
30
27.

D IFA RE 21 Ofloxacin 0 DOT 3 bott of 5 ml

Ofloxacin 0 DOT 3 bott of 5 ml

Qty:20
Unit:bott
30
28.

D IFA RE 21 Pilocarpine Nitrate eye solution 2 bott of 5 ml

Pilocarpine Nitrate eye solution 2 bott of 5 ml

Qty:15
Unit:bott
30
29.

D IFA RE 21 Pilocarpine Intracameral Inj 0 DOT 5 Pilocarpine nitrate intra ocular Inj without preservatives amp of 01ml each

Pilocarpine Intracameral Inj 0 DOT 5 Pilocarpine nitrate intra ocular Inj without preservatives amp of 01ml each

Qty:50
Unit:amp vial
30
30.

D IFA RE 21 Prednisolone acetate 1 w v bott of 5 ml

Prednisolone acetate 1 w v bott of 5 ml

Qty:25
Unit:bott
30
31.

D IFA RE 21 Sodium Chloride 6 w w ointment Tube of 3 gm

Sodium Chloride 6 w w ointment Tube of 3 gm

Qty:110
Unit:tube
30
32.

D IFA RE 21 Azelaic acid 20 cream tube of 15 gm

Azelaic acid 20 cream tube of 15 gm

Qty:300
Unit:tube
30
33.

D IFA RE 21 Cream Luliconazole tube of 15 gm

Cream Luliconazole tube of 15 gm

Qty:200
Unit:tube
30
34.

D IFA RE 21 Tobramycin 0 DOT 3 bott of 5 ml

Tobramycin 0 DOT 3 bott of 5 ml

Qty:23
Unit:bott
30
35.

D IFA RE 21 Tropicamide 1 with 5 Phenylephrine eye drops bott of 5 ml

Tropicamide 1 with 5 Phenylephrine eye drops bott of 5 ml

Qty:140
Unit:bott
30
36.

D IFA RE 21 Tropicamide Eye solution 1 bott of 5 ml

Tropicamide Eye solution 1 bott of 5 ml

Qty:55
Unit:bott
30
37.

D IFA RE 21 Trypan Blue 0 DOT 6 Inj in vial of 1ml

Trypan Blue 0 DOT 6 Inj in vial of 1ml

Qty:30
Unit:amp vial
30
38.

D IFA RE 21 Amphotericin B 0 DOT 5 eye drops bott of 5 ml

Amphotericin B 0 DOT 5 eye drops bott of 5 ml

Qty:15
Unit:bott
30
39.

D IFA RE 21 Atropine Sulphate 1 w v Eye Drop Bott of 3 ml

Atropine Sulphate 1 w v Eye Drop Bott of 3 ml

Qty:20
Unit:bott
30
40.

D IFA RE 21 Atropine Sulphate Oint 1 Tube of 3gm

Atropine Sulphate Oint 1 Tube of 3gm

Qty:30
Unit:tube
30
41.

D IFA RE 21 Olopatadine Hydrochloride 0 DOT 1 Ophthalmic Soln Bott of 5ml

Olopatadine Hydrochloride 0 DOT 1 Ophthalmic Soln Bott of 5ml

Qty:30
Unit:bott
30
42.

D IFA RE 21 Olopatadine 0 DOT 2 Ophthalmic Soln bott of 5 ml

Olopatadine 0 DOT 2 Ophthalmic Soln bott of 5 ml

Qty:120
Unit:bott
30
43.

D IFA RE 21 Proparacaine Eye Drops 0 DOT 5 Bott of 5 ml

Proparacaine Eye Drops 0 DOT 5 Bott of 5 ml

Qty:150
Unit:bott
30
44.

D IFA RE 21 Moxifloxacin HCl 0 DOT 5 and Dexamethasone 0 DOT 1 Ophthalmic Soln Bott of 5ml

Moxifloxacin HCl 0 DOT 5 & Dexamethasone 0 DOT 1 Ophthalmic Soln Bott of 5ml

Qty:235
Unit:bott
30
45.

D IFA RE 21 Diphenhydramine 10 15 mg per 5 ml and Ammonium Chloride 100 150 mg Sodium Citrate 50 85 mg per 5ml Syp Bott of 100ml

Diphenhydramine 10 15 mg per 5 ml and Ammonium Chloride 100 150 mg Sodium Citrate 50 85 mg per 5ml Syp Bott of 100ml

Qty:645
Unit:no
30
46.

D IFA RE 21 Beclomethasone Dipropionate nasal spray 50 mcg per dose metered dose 150 units

Beclomethasone Dipropionate nasal spray 50 mcg per dose metered dose 150 units

Qty:165
Unit:bott
30
47.

D IFA RE 21 Betahistine Dihydrochloride 16mg Tab

Betahistine Dihydrochloride 16mg Tab

Qty:620
Unit:no
30
48.

D IFA RE 21 Clotrimazole 1 w v IP Lignocaine 2 w v IP ear drop bott of 10ml

Clotrimazole 1 w v IP Lignocaine 2 w v IP ear drop bott of 10ml

Qty:120
Unit:bott
30
49.

D IFA RE 21 Chloramphenicol 5 w v Clotrimazole 1 w v Betamethasone 0 DOT 25 w v Lignocaine HCl 2 w v in bott of 5 ml

Chloramphenicol 5 w v Clotrimazole 1 w v Betamethasone 0 DOT 25 w v Lignocaine HCl 2 w v in bott of 5 ml

Qty:210
Unit:bott
30
50.

D IFA RE 21 Xylometazoline HCl 0 DOT 05 w v nasal solution for paed use bott of 10ml

Xylometazoline HCl 0 DOT 05 w v nasal solution for paed use bott of 10ml

Qty:400
Unit:bott
30

General Information

Item Category
D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Disposable Pen with 5 needles per pen , D IFA RE 21 Gliclazide MR 30 mg Tab , D IFA RE 21 Glipizide 5mg Tab , D IFA RE 21 Sitagliptin 50 mg Metformin 1000 mg Tab , D IFA RE 21 Insulin Lispro Biphasic injection I DOT P 25 Insulin Lispro and 75 Insulin Lispro protamine suspension , D IFA RE 21 Sirolimus 1mg Tab , D IFA RE 21 Pioglitazone Hydrochloride 15mg Tab , D IFA RE 21 Alendronate Sodium 70mg Tab , D IFA RE 21 Neostigmine 0 DOT 5mg 1ml Inj , D IFA RE 21 Cisatracurium 2 mg ml Inj 10ml vial , D IFA RE 21 Tacrolimus 1mg Prolonged Release Cap , D IFA RE 21 Mycophenolate Mofetil 750mg Tab , D IFA RE 21 Intravenous Immunoglobulin IvIg 10gm Bott of 50ml , D IFA RE 21 Calcium Phosphate 0 DOT 24 mg 5 ml Syp , D IFA RE 21 Calcium Acetate 500 mg Tab , D IFA RE 21 Carnitine 200 mg Tab , D IFA RE 21 Acyclovir Ophth Ointment 3 w w in 5 gm tube , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Tube of 5 gm , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Dexamethasone DOT 1 bott of 5ml , D IFA RE 21 Cyclosporine eye drop 0 DOT 05 bott of 3 ml , D IFA RE 21 Fluorescein Sodium 20 3 ml Inj , D IFA RE 21 Flurbiprofen Sodium ophthalmic soln 0 DOT 03 vial of 5 ml , D IFA RE 21 Homatropine Hydrochloride Soln 2 , D IFA RE 21 Ketorolac Tromethamine 0 DOT 4 Eye drops , D IFA RE 21 Natamycin 3 eye drops in 3 ml bott , D IFA RE 21 Carboxy Methyl Cellulose CMC 1 Gel , D IFA RE 21 Ofloxacin 0 DOT 3 bott of 5 ml , D IFA RE 21 Pilocarpine Nitrate eye solution 2 bott of 5 ml , D IFA RE 21 Pilocarpine Intracameral Inj 0 DOT 5 Pilocarpine nitrate intra ocular Inj without preservatives amp of 01ml each , D IFA RE 21 Prednisolone acetate 1 w v bott of 5 ml , D IFA RE 21 Sodium Chloride 6 w w ointment Tube of 3 gm , D IFA RE 21 Azelaic acid 20 cream tube of 15 gm , D IFA RE 21 Cream Luliconazole tube of 15 gm , D IFA RE 21 Tobramycin 0 DOT 3 bott of 5 ml , D IFA RE 21 Tropicamide 1 with 5 Phenylephrine eye drops bott of 5 ml , D IFA RE 21 Tropicamide Eye solution 1 bott of 5 ml , D IFA RE 21 Trypan Blue 0 DOT 6 Inj in vial of 1ml , D IFA RE 21 Amphotericin B 0 DOT 5 eye drops bott of 5 ml , D IFA RE 21 Atropine Sulphate 1 w v Eye Drop Bott of 3 ml , D IFA RE 21 Atropine Sulphate Oint 1 Tube of 3gm , D IFA RE 21 Olopatadine Hydrochloride 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Olopatadine 0 DOT 2 Ophthalmic Soln bott of 5 ml , D IFA RE 21 Proparacaine Eye Drops 0 DOT 5 Bott of 5 ml , D IFA RE 21 Moxifloxacin HCl 0 DOT 5 and Dexamethasone 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Diphenhydramine 10 15 mg per 5 ml and Ammonium Chloride 100 150 mg Sodium Citrate 50 85 mg per 5ml Syp Bott of 100ml , D IFA RE 21 Beclomethasone Dipropionate nasal spray 50 mcg per dose metered dose 150 units , D IFA RE 21 Betahistine Dihydrochloride 16mg Tab , D IFA RE 21 Clotrimazole 1 w v IP Lignocaine 2 w v IP ear drop bott of 10ml , D IFA RE 21 Chloramphenicol 5 w v Clotrimazole 1 w v Betamethasone 0 DOT 25 w v Lignocaine HCl 2 w v in bott of 5 ml , D IFA RE 21 Xylometazoline HCl 0 DOT 05 w v nasal solution for paed use bott of 10ml
Ministry Name
Ministry of Defence
Department Name
Department of Military Affairs
Organisation Name
Indian Army
State
West bengal
City
Darjeeling

Financial Information

Estimated Bid Value
₹10,26,465.00
EMD Amount
₹158.00
Bid Offer Validity
180 (Days)
Past Performance
80 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

6 Documents
GeM-Bidding-7757124.pdfMain Document
Other DocumentsOTHER COMPLIANCE
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Additional Doc 1 (Requested in ATC)
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

D IFA RE 24 Cycloserine 250 mg Cap,D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml

₹6.00
GEM
Goods
Qty:19.3K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA RE 24 Cycloserine 250 mg Cap , D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml , D IFA RE 24 Fluticasone propionate inhaler for paed use 50mcg dose 120 metered doses , D IFA RE 24 Fluticasone Propionate Inhaler for Adults 125 mcg dose , D IFA RE 24 Salmeterol 50 mcg plus Fluticasone 250 mcg multi dose dry powder inhaler of 60 doses , D IFA RE 24 Salmeterol Rotacap 50mcg , D IFA RE 24 Theophylline SR 400 mg Tab , D IFA RE 24 Fexofenadine Hydrochloride Tab 120 mg , D IFA RE 24 Glucosamine 250 mg plus Chondroitin Sulphate 200 mg Cap , D IFA RE 24 Immunoglobulin Intravenous 2 DOT 5 gm Inj , D IFA RE 24 Ibuprofen Gel tube of 20 gm , D IFA RE 24 Leflunomide 20 mg Tab , D IFA RE 24 Naproxen gel tube of 20 gm , D IFA RE 24 Nimesulide gel tube of 20 gm , D IFA RE 24 Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml , D IFA RE 24 Amikacin Sulphate 250 mg 2 ml Inj , D IFA RE 24 Norfloxacin 400 mg Tab , D IFA RE 24 Ofloxacin 200 mg Tab , D IFA RE 24 Sulphamethoxazole 200 mg and Trimethoprim 40 mg per 5 ml bottle of 50 60 ml suspension , D IFA RE 24 Sulphamethoxazole 400 mg and Trimethoprim 80 mg Tab , D IFA RE 24 Acyclovir 250 mg Inj , D IFA RE 24 Acyclovir Syp 400 mg 5 ml , D IFA RE 24 Linezolid 2 mg ml 300 ml Inj , D IFA RE 24 Oseltamivir 75 mg Cap , D IFA RE 24 Brimonidine 0 DOT 2 and Brinzolamide 1 Eye Drop Bott of 5ml , D IFA RE 24 Nepafenac mocronised suspension 0 DOT 1 BAK free in 5 ml bottle , D IFA RE 24 Nitroglycerine Glyceryltrinitrate 5mg Inj , D IFA RE 24 Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 ml bottle , D IFA RE 24 Methotrexate 15mg Tab , D IFA RE 24 Paroxetine 25mg Tab , D IFA RE 24 Baclofen XL 30 mg Tab , D IFA RE 24 Clozapine 50 mg Tab , D IFA RE 24 Thiamine 100mg ml Inj 2ml Amp , D IFA RE 24 MDI spacer with mask and fish mouth valve for pediatrics set , D IFA RE 24 Fluticasone Propionate and Formoterol 120 MDI , D IFA RE 24 Cabergoline 0 DOT 25mg Tab , D IFA RE 24 Misoprostol 600mcg Tab , D IFA RE 24 Diclofenac 75mg ml Inj 1ml Amp for IV bolus , D IFA RE 24 Silicone Ring Vaginal Pessary , D IFA RE 24 Cell Culture Rabies Vaccine vial of 1 ml , D IFA RE 24 Test Mantoux Sufficent for 10 tests , D IFA RE 24 Airway long transparent Oropharyngeal set consisting of size Length 000 3 DOT 5 00 5 DOT 0 0 5 DOT 0 1 7 DOT 0 2 9 DOT 0 3 10 DOT 0 4 1 DOT 0 , D IFA RE 24 Adhesive Incise drape 50 x 45 cm , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 0 infant , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 1 paediatric , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 3 adult with valve , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 4
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

Desmopressin 0 point 1 mg tab,Eye Drop Olapatadine plus Ketorolac,Ketorolac Tromethamine 0 point 4

GEM
Goods
Qty:14.6K
4 Files
Indian Army
Boq › Boql
Desmopressin 0 point 1 mg tab , Eye Drop Olapatadine plus Ketorolac , Ketorolac Tromethamine 0 point 4 percent Eye Drop Eye Drop , Olapatadine Eye Drop , Linseed Oil Diclofenac Diethylamine Methyl Salicylate and Methnol Spray , Softgel Cap of Coenzyme Q 10 Lycopene Omega 3 fatty acid , Softgel Cap of Coenzyme Q 300 , Protein Powder Bott of 500 gm , Lumbar Belt Size S M L XL and XXL , Cervical Collar Soft Size0S M L Xl , Knee Cap Size0M L and XL , Arm sling pouch , Compression Stocking Above Knee Size S M L , Compression Stocking Below Knee Size S M L , Benzoyl peroxide 2 point 5 percent tube of 20 gm Oint , Alprazolam of 0 point 25 mg Tab , Syp Chloropheniramine 2 mg and Phenylephrine 5 mg , Tab Bosentan 125 mg , Evening Primrose Cap 500mg , Hand Gloves sterile Size06 point 5 , Hand Gloves sterile Size07 , Hand Gloves sterile Size07 point 5 , Dextrose monohydrate for oral use Pack of 500 gm , Tab Rose Hip rugosa , Tenofovir 300 mg plus Emitractabine 200mg plus Efavirenz 600mg combination pill , Tab Ketorolac 10 mg DT , Alprazolam 0 point 5 mg Tab , Ankle strap size S M L , Ethambutol 800 mg Tab , Rifampicin 450mg plus Isoniazid 300mg Tab , Thyroxin sodium 75 mcg Tab , Ketoconazole lotion 2percent ZincPyrithione 1 percent w v Shampoo Bott of 100ml , Ketoconazole lotion 2 percent Zinc Pyrithione 1 percent w v Lotion Bott of 100ml , Hydrocortisone Sodium Succininate Inj 100 mg Inj , Salmeterol 25mcg plus Fluticasone 250 mcg autohaler , Betamethasone 0 point 1 percent plus Salicylic Acid 3 percent Cream 20gm Tube , Antispasmodic Tab Containing Mefenamic Acid 250mg and Dicyclomine HCL 10mg , Cough Syrup Each 5ml contains Chlorpheniramine maleate IP 3mg Ammounium Chloride IP 110mg Sodium Citrate IOP 46mg Menthol IP 0 point 9mg , Povidone Iodine 10 percent solution bott of 100 ml , Miconazole nitrate and Fluocinolone Acetonide Oint , Bromhexine 5 ml containing 4 mg of Bromhexine Hcl Bott of 100ml Syp , Tab Teriflunomide 14 mg , Syp LIV 52 , Norfloxacin 0 point 3 percent eye drops 3 mg per ml bott of 5 ml Eye Drop , Povidone iodine gargle bott of 100 ml , Tab Tramadol and Paracetamol , cholrhexidine mouth wash , Bandage Triangular Cotton woven 100x100x141 cm , Gum Paint
April 29, 2025
May 20, 2025 at 2:00 PM
View Details

HUMAN INSULINE ANALOGUE GLARGINE INJ 100IU/ML(RECOMBINANT DNA ORIGIN) 300 IU DISPOSABLE PEN WITH 5

GEM
Goods
Qty:210
4 Files
Indian Air Force
Univ
HUMAN INSULINE ANALOGUE GLARGINE INJ 100IU/ML(RECOMBINANT DNA ORIGIN) 300 IU DISPOSABLE PEN WITH 5 N
April 28, 2025
May 19, 2025 at 1:00 PM
View Details

Ivermectin 12 mg Tab,Corn Cap 40 percent Sallicylic Acid,Miconazole Nitrate 2 percent Ung 15 gm,Cap

GEM
Goods
Qty:29.3K
4 Files
Indian Army
AMBALA, HARYANA
Boq › Boql
Ivermectin 12 mg Tab , Corn Cap 40 percent Sallicylic Acid , Miconazole Nitrate 2 percent Ung 15 gm , Cap Minocycline ER 65 mg , Hydrous Benzoyl Peroxide IP FACE WASH 4 percent of 50 , Clindamycin 1 percent w v Benzoyl peroxide 5 percent w w , Clindamycin 1 percent plus Nicotinamide 4 percent 20 gm tube , Clobetasol Propionate 0 point 05 percent plus Buffered lactic acid , Cyclophosphamide 500 mg Inj , Gel Luliconazole 1 percent with Sepineo and Biochitoderm , Halobetasol proprionate 0 point 05 percent cream 50 gm , Hydrocortisone Acetate Cream 1 percent Tube of 15 gm , Inj Bleomycin Sulphate 15 Units , inj Triamcinolone Acetate 10Mg ml , Lot Clotrimazole 1 percent plus Beclomethasone 0 point 0 , Lot Minoxidil 10 percent Bott of 60ml , 50 precent Glycolic acid Peel 60ml with Pre Peel liposomal , Aloevera 10 point 0 percent Vitamin E 0 point 5 percent , Azelaic Acid 20percent Cream Tube of 15 gm , Mometasone Lotion 0 point 1 percent Tube of 15ml , PRP kit , Tab Minoxidil 2 point 5 mg , Tacrolimus ointment 0 point 03 percent Tube of 20 gram , Tretinoin gel 0 point 025 percent tube of 20 gram , Yellow Peel Kit 10 percent Ascorbyl Glucoside and 5 percent , Zinc Oxide and Benzalkonium chloride cream tube of 30 gram , 0 point 1 percent Triamcinolone Acetonide Bucccal Parts , White Soft Paraffin ,Light Liquid Paraffin,Light Liquid Paraffin , Ivermectin 6mg Tab , Luliconazole 1 percent Cream 30gm , Minoxidil 2 percent Lotion 60 ml , Methotrexate LP Liposomal topical gel 1 percent Tube , Minoxidil 5 percent wv plus Finasteride 0 point 1 , Bilastine 10 mg Tab , Ketoconazole 2 percent and Salicyclic acid 2 percent , Tab Fluconazole 400 mg Tab , Ciclopiroxolamine 1 percent Cream 30gm , Deca Peptide Solution of 2 ml , Triamcinolone Acetonide 40mg Inj , Lot lacquer nail amorlfine 5 percent 2 point 5ml , Disposable skin biopsy punches size 5 mm , Disposable skin biopsy punches size 6 mm , 0 point 4 percent Tretinoin Microsphere gel Tube of 20 gm , Ciclopirox 1 percent Zinc Pyrithidone 1 percent , Clotrimazole 1 percent plus Selenium Sulphate 2 point 5 percent , Lactic Acid 17 percent Salicylic Acid 17 percent isopropyl alcohol , Amorolfine 0 point 25percent Ung 20 gm , Imiquimod 5percent Ung , Adapalene 0 point 1 percent Tube of 15 gm , Tacrolimus Oint 0 point 1 percent 20 gm tube , Benzoyl Peroxide 2 point 5 percent Tube of 20 gm , Lot Octinoxate 7 point 5 percent plus Oxybenzone 3 percent plus , Disposable Miniature Punches Size 3 mm , Disposable miniature punches size 4 mm , Ung Kojic acid 3percent vit c 15gm , Clindamycin phosphate 1 percent topical gel Tube of 10 gm , Fluticasone 0 point 05percent oint Tube of 10 gm , Permethrin 5 percent Tube of 30 gm , Podophyllin Resin 20 percent bott of 10 ml , Halobetasol proprionate lotion 0 point 05 percent , Eberconazole Ung 30 gm , Fluocinolone acetonide 0 point 01 percent Hydroquinone , Valacyclovir 1gm Tab , Tofacitinib 2 percent cream tube of 30 gm
April 25, 2025
May 16, 2025 at 11:00 AM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity, having necessary certifications for pharmaceutical products, and demonstrating prior experience in delivering similar items to government or large institutions. Additionally, bidders must comply with regulatory standards and quality assurance protocols relevant to pharmaceuticals.

Bidders must provide D IFA RE 21 Human Insulin Analogue that is a long-acting insulin analogue with a concentration of 100 IU/ml. It must be manufactured from recombinant DNA technology and packaged in disposable pens, each with 5 needles. Compliance with Good Manufacturing Practices and certifications from relevant health authorities is required.

All tender documents must be submitted via the designated online procurement platform in the required format. This includes making sure files are correctly labeled and all necessary documents are complete. Visitors are urged to check for additional submission guidelines specific to this tender.

Yes, there are dedicated provisions to support Micro, Small, and Medium Enterprises (MSEs) and startups. Eligible bidders should submit relevant certifications to claim these benefits, aligning their proposals with initiatives like Make in India to enhance local procurement.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders